Access to state-of-the-art sequencing for industry partners

Dr Amanda Swain is Head of the Tumour Profiling Unit at the ICR, providing access to state-of-the-art sequencing technologies and unrivalled expertise in the molecular characterisation of tumours. She is interested in partnering with different pharmaceutical companies to look at novel drugs that are being developed, to see if they can be combined with drugs that are currently used in the clinic. Watch our full series of videos:

Amanda Swain,The ICR,Institute of Cancer Research,Clinical Trials,Tumour Profiling Unit,next-generation sequencing,